1. Markovich, Daniel. . Sodium-sulfate/carboxylate cotransporters (SLC13). In Current topics in membranes, 70, 239-56. doi:10.1016/B978-0-12-394316-3.00007-7. https://pubmed.ncbi.nlm.nih.gov/23177988/
2. Udomsilp, Pattarin, Saepoo, Sarawut, Ittiwut, Rungnapa, Boonla, Chanchai, Tosukhowong, Piyaratana. 2018. rs11567842 SNP in SLC13A2 gene associates with hypocitraturia in Thai patients with nephrolithiasis. In Genes & genomics, 40, 965-972. doi:10.1007/s13258-018-0702-4. https://pubmed.ncbi.nlm.nih.gov/30155711/
3. Shi, Li, Chen, Hao, Zhang, Yuxin, Hao, Haiping, Xiong, Jing. 2025. SLC13A2 promotes hepatocyte metabolic remodeling and liver regeneration by enhancing de novo cholesterol biosynthesis. In The EMBO journal, 44, 1442-1463. doi:10.1038/s44318-025-00362-y. https://pubmed.ncbi.nlm.nih.gov/39824985/
4. Akhtar, Md Jawaid, Khan, Shah Alam, Kumar, Bhupinder, Bhatia, Rohit, Singh, Karanvir. 2022. Role of sodium dependent SLC13 transporter inhibitors in various metabolic disorders. In Molecular and cellular biochemistry, 478, 1669-1687. doi:10.1007/s11010-022-04618-7. https://pubmed.ncbi.nlm.nih.gov/36495372/
5. Markovich, Daniel, Murer, Heini. 2003. The SLC13 gene family of sodium sulphate/carboxylate cotransporters. In Pflugers Archiv : European journal of physiology, 447, 594-602. doi:. https://pubmed.ncbi.nlm.nih.gov/12915942/
6. Rendina, Domenico, De Filippo, Gianpaolo, Gianfrancesco, Fernando, Strazzullo, Pasquale, Esposito, Teresa. 2016. Evidence for epistatic interaction between VDR and SLC13A2 genes in the pathogenesis of hypocitraturia in recurrent calcium oxalate stone formers. In Journal of nephrology, 30, 411-418. doi:10.1007/s40620-016-0348-8. https://pubmed.ncbi.nlm.nih.gov/27639591/